Pet Scan

Evidence of amyloid abnormality across the Alzheimer’s disease spectrum is more prevalent with cerebrospinal fluid testing, according to a cross-sectional, individual-participant pooled study published in JAMA Neurology.

Entorhinal hypometabolism identified on fluorodeoxyglucose PET scans served as a “strong and independent predictor” of future cognitive decline in preclinical Alzheimer’s disease, according to findings from a prospective cohort study.

When examined with an FDA-approved, clinically relevant method, flortaucipir PET scans provided “valuable information” about risk for clinical decline in patients with Alzheimer’s disease and mild cognitive impairment, according to a study.

PET-guided strategy improved the safety of BEACOPP-based treatment in advanced Hodgkin lymphoma, according to prolonged follow-up data from the AHL 2011 phase 3 study presented at the ASH Annual Meeting and Exposition.

A survey of advanced CV imaging programs found that they are as diverse in their size and trainees as the programs are in actual training and effect on subsequent clinical practice.

Researchers have found lower levels of a protein associated with neural connections in the living brains of people with schizophrenia, according to results of parallel clinical and preclinical studies published in Nature Communications.